Evaluation of Treatment Patterns and Direct Costs Associated with the Management of Neuropathic Pain
Background. Neuropathic pain has a prevalence of 2–17% in the general population. Diagnosis and treatment of neuropathic pain are not fully described in different populations. The aim was to determine the treatment patterns and direct costs of care associated with the management of neuropathic pain...
Main Authors: | Manuel E Machado-Duque, Andres Gaviria-Mendoza, Jorge E Machado-Alba, Natalia Castaño |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Pain Research and Management |
Online Access: | http://dx.doi.org/10.1155/2020/9353940 |
Similar Items
-
Opstacles in neuropathic pain treatment in the developing country: Neuropathic pain treatment
by: Jovičić Jelena, et al.
Published: (2018-01-01) -
Real-World Effectiveness of Therapy With Rosuvastatin Combined With Fenofibric Acid in a Sample of Colombian Patients With Mixed Dyslipidemia
by: Manuel E. Machado-Duque, et al.
Published: (2020-11-01) -
Lipid-lowering drug prescriptions in a group of Colombian patients
by: Andres Gaviria-Mendoza, et al.
Published: (2019-12-01) -
Results of the effectiveness of two piperacillin–tazobactam molecules in the real world
by: Jorge Enrique Machado-Alba, et al.
Published: (2018-11-01) -
Additional tests to investigate neuropathic pain. The value of electroneuromyography for neuropathic pain
by: Fábio Henrique de Gobbi Porto, et al.